Awaiting development: Guidance and quality standards
Showing 341 to 344 of 344
| Title | Type |
|---|---|
| Zavegepant for treating acute migraine [TSID11998] | Technology appraisal guidance |
| Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer [ID6444] | Technology appraisal guidance |
| Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer [TSID12040] | Technology appraisal guidance |
| Zongertinib for untreated HER2-positive unresectable advanced non-small-cell lung cancer [TSID12179] | Technology appraisal guidance |